GracePMakari-JudsonMD

Oncology • Springfield, MA

Breast Cancer, Cancer Genetics/Cancer Risk Assessment

Professor of Medicine, University of Massachusetts Medical School-Baystate

Join to view full profile

Dr. Makari-Judson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Makari-Judson's full profile

Already have an account?

Office
3350 Main St
Springfield, MA 01107
Phone+1 413-794-9338

Fax+1 413-794-9754

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1985 - 1988
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1982 - 1985
Weill Cornell MedicineClass of 1982

Certifications & Licensure

NY State Medical License 1983 - Present
MA State Medical License 1988 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

A Home-Based Study to Enhance Activity in Breast Cancer Survivors Start of enrollment: 2016 Oct 01
Completed
Not Applicable

Publications & Presentations

PubMed

106 citations
Weight gain following breast cancer diagnosis: Implication and proposed mechanisms.
Grace Makari-Judson, Barry Braun, D. Joseph Jerry, Wilson C. Mertens
World Journal of Clinical Oncology. 2014-08-10
15 citations
Bisphenol-A in breast adipose tissue of breast cancer cases and controls.
Katherine W. Reeves, Sallie S. Schneider, Jingchuan Xue, Kurunthachalam Kannan, Holly Mason
Environmental Research. 2018-08-31
51 citations
Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2–Negative Advanced Breast Cancer That Progressed during or after Bevacizumab
Lee S. Schwartzberg, Kurt W. Tauer, Robert Hermann, Grace Makari-Judson, Claudine Isaacs
Clinical Cancer Research. 2013-05-15

Press Mentions

Breast Cancer Risk Factors for Women Under 45 Years OldOctober 5th, 2022
Clinical Breast Exam May Not Be Needed for Follow-UpJuly 1st, 2022
Rays of Hope Marks 25th Year in Battle Against Breast CancerOctober 3rd, 2018
Join now to see all